TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/28/22 16:33 | 11/22/22 | LPCN | Lipocine Inc. | DE | Health | Drug | Pharmaceutical Preparations | Papapetropoulos Spyros | UT | D | P | 10 | 0.4700 | 0 | 22 | New | 22 | D | |||||||||||||||
11/22/22 21:45 | 11/18/22 | VIGL | Vigil Neuroscience, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Papapetropoulos Spyros | MA | O | Chief Me | M.d | 1 | 1.89 | 0 | 0 | 8 | 4 | D | ||||||||||||||
11/22/22 21:45 | 11/18/22 | VIGL | Vigil Neuroscience, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Papapetropoulos Spyros | MA | O | Chief Me | S.d | -4 | 14.00 | 0 | 0 | -7 | 4 | D | ||||||||||||||
5/4/22 07:00 | 5/3/22 | VIGL | Vigil Neuroscience, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Papapetropoulos Spyros | MA | O | Chief Me | P | 14 | 3.40 | 0 | 4 | New | 4 | D | ||||||||||||||
3/15/21 15:24 | 3/11/21 | ADMS | Adamas Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Papapetropoulos Spyridon | CA | D | P | 30 | 5.06 | 0 | 6 | 60 | 16 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |